They have benchmark product. That's what's important.
Consumers know Elixinol is a superior product and they rave on about it.
So imo as the market grows out of its infancy, Elixinol will have the numbers.
As far as doubling inventory goes, I can't find any information confirming that what you're saying about Elixinol not having a strong enough market to sell their products.
I've seen their products on sale up to 40% off, however not everywhere. Mostly I've seen it at 10% - 20% discount.
It's probably more marketing than over stock Imo.
I don't know, so beware. Your capital is at risk regardless of what stock you buy.
Disallowed imo
They have benchmark product. That's what's important. Consumers...
Add EXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $6.505M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $10.01K | 2.002M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 3660204 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 7345956 | 17 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
0.5¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.5¢ | 0.5¢ | 0.5¢ | 892486 | ||
| Last updated 15.45pm 03/05/2024 ? | |||||
| EXL (ASX) Chart |